Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2026-02-07 @ 12:54 AM
Study NCT ID:
NCT02141295
Status:
TERMINATED
Last Update Posted:
2020-03-25
First Post:
2014-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-15
First Submit QC Date:
None
Study First Post Date:
2014-05-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-06
Results First Submit QC Date:
None
Results First Post Date:
2020-03-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-01-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-03-11
Last Update Post Date:
2020-03-25
Last Update Post Date Type:
ACTUAL